UroGen Pharma Ltd
(NAS:URGN)
$
13.05
-0.76 (-5.5%)
Market Cap: 549.59 Mil
Enterprise Value: 437.91 Mil
PE Ratio: 0
PB Ratio: 18.74
GF Score: 72/100 
Urogen Pharma Ltd at Jefferies Healthcare Conference Transcript
Jun 09, 2023 / 04:45PM GMT
Release Date Price:
$11.65
(+5.33%)
Chris Howerton
(Trades, Portfolio), Inc. - Moderator
Okay. All right. Thanks, everybody, for joining us and sticking around until the end of the conference. My name is Chris Howerton, part of the Jefferies biotechnology research team. Really excited to see everybody here, and of course, to be hosting a fireside chat with one of the great companies I cover UroGen.
And on behalf of the company, we have the CEO, Liz Barrett. So thanks for joining us.
Liz Barrett;Chris Howerton
UroGen Pharma Ltd. - CEO, President; (
Hi, thanks, Chris. Thanks for having me.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers